Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Revista Espanola de Anestesiologia y Reanimacion 1999-Apr

[Ondansetron in the prophylaxis of postoperative nausea and vomiting in ambulatory cataract surgery].

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Le lien est enregistré dans le presse-papiers
L M Arregui
M S Leonato
M D Vigil
J M Pérez de Cossío
A Cardona
J M Martínez de la Casa

Mots clés

Abstrait

OBJECTIVE

Postoperative nausea and vomiting (PONV) are potentially serious complications of ophthalmic surgery. We assess the efficacy of ondansetron for antiemetic prophylaxis in outpatient unilateral cataract surgery under retrobulbar blockade.

METHODS

Cohort study of patients undergoing unilateral cataract surgery between January 1996 and March 1997. The main predictive variable was intravenous administration of 4 mg of ondansetron 30 min before surgery and the main effect variable was the presence of PONV during the first 24 h after surgery. The incidence of PONV was calculated and an analysis of statistical significance was performed using a Mantel-Haenszel chi 2 test, describing the magnitude of association between relative risk and the corresponding confidence interval (95% CI).

RESULTS

One hundred sixty-two patients were enrolled. Eighty-two patients received ondansetron and 80 did not. The two groups were similar with respect to control variables. PONV occurred in 23 patients (14.2%): in 16 (20%) who did not receive ondansetron and in 7 (8.2%) who did (p < 0.05). The relative risk of patients who received ondansetron was 0.42 (95% CI: 0.19-0.98) in comparison with those who did not.

CONCLUSIONS

We found a high incidence of PONV, although the administration of ondansetron reduced PONV significantly.

Rejoignez notre
page facebook

La base de données d'herbes médicinales la plus complète soutenue par la science

  • Fonctionne en 55 langues
  • Cures à base de plantes soutenues par la science
  • Reconnaissance des herbes par image
  • Carte GPS interactive - étiquetez les herbes sur place (à venir)
  • Lisez les publications scientifiques liées à votre recherche
  • Rechercher les herbes médicinales par leurs effets
  • Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets

Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées

Google Play badgeApp Store badge